NCT00868166 Safety and Efficacy of TRO19622 as add-on Therapy to Riluzole Versus Placebo in Treatment of Patients Suffering From ALS Status COMPLETED Phase PHASE3
NCT00866840 Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery Status COMPLETED Phase PHASE2
NCT00818389 Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS) Status TERMINATED Phase PHASE2/PHASE3
NCT00805493 Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder Status TERMINATED Phase PHASE2
NCT00774423 Study to Evaluate the Efficacy of Riluzole in Children and Young Adults With Spinal Muscular Atrophy (SMA) Status COMPLETED Phase PHASE2/PHASE3
NCT00667901 Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery Status TERMINATED Phase PHASE1
NCT00523718 Riluzole Augmentation in Treatment-refractory Obsessive-compulsive Disorder Status COMPLETED Phase PHASE2
NCT00501943 Neuroprotection With Riluzole Patients With Early Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00419003 Research Study for Major Depressive Disorder: Investigation of Glutamate Medications Status COMPLETED Phase PHASE4
NCT00376220 A Double-Blind Placebo Controlled Trial of Riluzole in Bipolar Depression Status COMPLETED Phase PHASE2
NCT00353665 Memantine for Disability in Amyotrophic Lateral Sclerosis (MEDALS) Status COMPLETED Phase PHASE2/PHASE3
NCT00283309 Memantine or Riluzole Prophylaxis for Corticosteroid-induced Mood and Declarative Memory Changes Status TERMINATED Phase PHASE4
NCT00251303 Riluzole to Treat Child and Adolescent Obsessive-Compulsive Disorder With or Without Autism Spectrum Disorders Status COMPLETED Phase PHASE2
NCT00211224 Neuroprotection and Natural History in Parkinson's Plus Syndromes (NNIPPS) Status TERMINATED Phase PHASE3
NCT00202397 Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia Status COMPLETED Phase PHASE2